Environment

How ‘green’ inhalers could evade Biden’s drug pricing legacy

Published

2 weeks ago

on

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce inhaler costs for patients. “Climate-friendly inhalers” could jeopardize those wins.
Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version